| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Epigenesis, Genetic | 7 | 2020 | 711 | 2.56 | Why? |
| Histocompatibility | 3 | 2019 | 53 | 2.12 | Why? |
| Legislation, Food | 2 | 2019 | 8 | 1.54 | Why? |
| HLA-G Antigens | 2 | 2019 | 48 | 1.50 | Why? |
| Isoantibodies | 2 | 2017 | 134 | 1.22 | Why? |
| HLA Antigens | 2 | 2017 | 830 | 0.88 | Why? |
| Ice Cream | 1 | 2019 | 1 | 0.80 | Why? |
| Antipyretics | 1 | 2020 | 107 | 0.80 | Why? |
| Tuberculin Test | 2 | 2018 | 141 | 0.79 | Why? |
| Histocompatibility Testing | 2 | 2017 | 219 | 0.79 | Why? |
| Nitric Oxide Synthase Type III | 1 | 2019 | 87 | 0.75 | Why? |
| Food Labeling | 1 | 2018 | 18 | 0.74 | Why? |
| Sirtuin 2 | 1 | 2017 | 8 | 0.72 | Why? |
| Molecular Imaging | 1 | 2019 | 110 | 0.71 | Why? |
| Heart Transplantation | 2 | 2019 | 1293 | 0.68 | Why? |
| Alternative Splicing | 1 | 2017 | 82 | 0.68 | Why? |
| Regenerative Medicine | 1 | 2019 | 161 | 0.68 | Why? |
| Mediator Complex | 2 | 2017 | 9 | 0.66 | Why? |
| Endothelial Progenitor Cells | 1 | 2017 | 103 | 0.63 | Why? |
| Epigenomics | 1 | 2017 | 139 | 0.63 | Why? |
| HLA-DR Antigens | 1 | 2019 | 563 | 0.63 | Why? |
| Blood Grouping and Crossmatching | 1 | 2016 | 125 | 0.62 | Why? |
| Hemoglobinopathies | 1 | 2016 | 90 | 0.62 | Why? |
| Legionellosis | 2 | 2018 | 31 | 0.62 | Why? |
| Nitric Oxide | 2 | 2019 | 769 | 0.60 | Why? |
| Captopril | 2 | 2017 | 39 | 0.60 | Why? |
| beta-Thalassemia | 1 | 2018 | 200 | 0.59 | Why? |
| Stem Cell Transplantation | 2 | 2019 | 531 | 0.59 | Why? |
| Hepatitis E virus | 1 | 2019 | 306 | 0.58 | Why? |
| Waiting Lists | 3 | 2018 | 1388 | 0.58 | Why? |
| Heart Failure | 5 | 2020 | 6638 | 0.57 | Why? |
| Interferon-gamma Release Tests | 1 | 2017 | 253 | 0.56 | Why? |
| Immunoenzyme Techniques | 1 | 2017 | 448 | 0.55 | Why? |
| Hospitals, Teaching | 2 | 2020 | 1609 | 0.55 | Why? |
| Hepatitis E | 1 | 2019 | 319 | 0.55 | Why? |
| Neovascularization, Physiologic | 2 | 2019 | 160 | 0.55 | Why? |
| Blood Group Antigens | 1 | 2016 | 202 | 0.54 | Why? |
| Genotyping Techniques | 1 | 2016 | 360 | 0.54 | Why? |
| Arterial Occlusive Diseases | 1 | 2019 | 363 | 0.54 | Why? |
| Energy Metabolism | 1 | 2018 | 451 | 0.53 | Why? |
| End Stage Liver Disease | 1 | 2018 | 418 | 0.51 | Why? |
| Peripheral Arterial Disease | 1 | 2019 | 471 | 0.50 | Why? |
| Diabetes Mellitus, Type 1 | 2 | 2018 | 1969 | 0.50 | Why? |
| Coronary Disease | 1 | 2019 | 645 | 0.50 | Why? |
| Genetic Predisposition to Disease | 4 | 2020 | 4027 | 0.49 | Why? |
| Cell- and Tissue-Based Therapy | 1 | 2017 | 422 | 0.47 | Why? |
| RNA, Long Noncoding | 1 | 2017 | 408 | 0.47 | Why? |
| Blood Transfusion | 2 | 2018 | 1399 | 0.46 | Why? |
| Enalapril | 1 | 2011 | 54 | 0.44 | Why? |
| Hemangioblasts | 1 | 2009 | 1 | 0.42 | Why? |
| Hindlimb | 1 | 2009 | 21 | 0.42 | Why? |
| Legionella | 1 | 2010 | 91 | 0.41 | Why? |
| Italy | 22 | 2021 | 38444 | 0.41 | Why? |
| Gastrointestinal Tract | 1 | 2018 | 1113 | 0.40 | Why? |
| Carotid Arteries | 1 | 2011 | 182 | 0.38 | Why? |
| Rome | 2 | 2020 | 497 | 0.37 | Why? |
| Hepacivirus | 1 | 2018 | 1509 | 0.37 | Why? |
| Malnutrition | 1 | 2018 | 932 | 0.37 | Why? |
| Ventricular Dysfunction, Left | 1 | 2017 | 993 | 0.37 | Why? |
| Peripheral Vascular Diseases | 1 | 2009 | 133 | 0.36 | Why? |
| Genotype | 2 | 2019 | 4697 | 0.36 | Why? |
| Health Facilities | 2 | 2020 | 1230 | 0.35 | Why? |
| Sequence Analysis, RNA | 1 | 2017 | 2290 | 0.35 | Why? |
| Nutritional Status | 1 | 2018 | 1403 | 0.34 | Why? |
| Diabetes Mellitus, Experimental | 1 | 2009 | 192 | 0.34 | Why? |
| Kidney Transplantation | 2 | 2018 | 5397 | 0.34 | Why? |
| Bacteria | 1 | 2018 | 1897 | 0.33 | Why? |
| Cell Movement | 1 | 2011 | 695 | 0.33 | Why? |
| Cardiac Surgical Procedures | 1 | 2020 | 1931 | 0.33 | Why? |
| Food Safety | 2 | 2019 | 145 | 0.33 | Why? |
| Immunotherapy | 1 | 2021 | 2421 | 0.33 | Why? |
| Reagent Kits, Diagnostic | 1 | 2017 | 2149 | 0.32 | Why? |
| Legionella pneumophila | 2 | 2018 | 143 | 0.32 | Why? |
| Diabetes Mellitus, Type 2 | 2 | 2018 | 6166 | 0.32 | Why? |
| Bone Marrow Transplantation | 1 | 2009 | 343 | 0.31 | Why? |
| European Union | 3 | 2019 | 565 | 0.31 | Why? |
| RNA, Messenger | 2 | 2017 | 5131 | 0.31 | Why? |
| Gene Expression Profiling | 1 | 2017 | 3788 | 0.30 | Why? |
| Cardiovascular Diseases | 4 | 2020 | 11497 | 0.29 | Why? |
| Blood Donors | 1 | 2019 | 2956 | 0.29 | Why? |
| Myocardium | 1 | 2017 | 2323 | 0.29 | Why? |
| Students | 2 | 2020 | 5255 | 0.29 | Why? |
| Immunosuppressive Agents | 2 | 2021 | 6331 | 0.28 | Why? |
| Gastrointestinal Microbiome | 1 | 2018 | 1961 | 0.28 | Why? |
| MicroRNAs | 1 | 2017 | 1787 | 0.27 | Why? |
| Lipid Metabolism | 1 | 2008 | 572 | 0.26 | Why? |
| Transcriptome | 1 | 2017 | 3466 | 0.26 | Why? |
| Fever | 1 | 2020 | 7795 | 0.25 | Why? |
| Arteriosclerosis | 1 | 2002 | 50 | 0.25 | Why? |
| DNA Methylation | 2 | 2018 | 688 | 0.24 | Why? |
| Hospital Administration | 2 | 2020 | 650 | 0.24 | Why? |
| Humans | 56 | 2021 | 930598 | 0.24 | Why? |
| Trigeminal Neuralgia | 1 | 2021 | 19 | 0.23 | Why? |
| Water Supply | 2 | 2018 | 294 | 0.23 | Why? |
| Organ Transplantation | 1 | 2017 | 2616 | 0.23 | Why? |
| Extracorporeal Membrane Oxygenation | 1 | 2020 | 5002 | 0.23 | Why? |
| Pneumonia, Viral | 11 | 2020 | 243684 | 0.23 | Why? |
| Polymorphism, Genetic | 2 | 2019 | 1074 | 0.23 | Why? |
| Coronavirus Infections | 11 | 2020 | 253789 | 0.22 | Why? |
| Diabetes Mellitus | 3 | 2021 | 8207 | 0.22 | Why? |
| Kidney Failure, Chronic | 1 | 2017 | 3222 | 0.21 | Why? |
| Tuberculosis | 1 | 2017 | 2895 | 0.21 | Why? |
| Analgesics, Non-Narcotic | 1 | 2021 | 164 | 0.21 | Why? |
| Asymptomatic Infections | 1 | 2019 | 7218 | 0.20 | Why? |
| Minisatellite Repeats | 1 | 2019 | 53 | 0.20 | Why? |
| Red Meat | 1 | 2019 | 39 | 0.19 | Why? |
| Aflatoxins | 1 | 2018 | 7 | 0.19 | Why? |
| Euthyroid Sick Syndromes | 1 | 2021 | 150 | 0.19 | Why? |
| Respiratory Tract Infections | 1 | 2020 | 6817 | 0.19 | Why? |
| Aflatoxin B1 | 1 | 2018 | 13 | 0.19 | Why? |
| Nuts | 1 | 2018 | 22 | 0.19 | Why? |
| Polysorbates | 1 | 2019 | 125 | 0.19 | Why? |
| Air Microbiology | 2 | 2020 | 1322 | 0.19 | Why? |
| Bacterial Translocation | 1 | 2018 | 39 | 0.18 | Why? |
| Influenza, Human | 2 | 2020 | 10779 | 0.18 | Why? |
| Hepatitis Antibodies | 1 | 2019 | 100 | 0.18 | Why? |
| Squalene | 1 | 2019 | 196 | 0.18 | Why? |
| Health Policy | 1 | 2019 | 6242 | 0.18 | Why? |
| Water Microbiology | 2 | 2018 | 248 | 0.18 | Why? |
| Solid Phase Extraction | 1 | 2017 | 23 | 0.18 | Why? |
| Sus scrofa | 1 | 2019 | 205 | 0.18 | Why? |
| 3' Untranslated Regions | 1 | 2019 | 318 | 0.18 | Why? |
| Community-Acquired Infections | 1 | 2010 | 2328 | 0.18 | Why? |
| Nutritive Value | 1 | 2018 | 100 | 0.17 | Why? |
| Gene-Environment Interaction | 1 | 2018 | 127 | 0.17 | Why? |
| Water Pollution | 1 | 2017 | 51 | 0.17 | Why? |
| Hydrochlorothiazide | 1 | 2017 | 31 | 0.17 | Why? |
| Solubility | 1 | 2018 | 382 | 0.17 | Why? |
| Food Contamination | 1 | 2018 | 142 | 0.17 | Why? |
| Gene Expression Regulation, Developmental | 1 | 2017 | 159 | 0.16 | Why? |
| Parity | 1 | 2017 | 122 | 0.16 | Why? |
| Undocumented Immigrants | 1 | 2018 | 100 | 0.16 | Why? |
| Vasodilation | 1 | 2019 | 258 | 0.16 | Why? |
| Thrombosis | 1 | 2019 | 7504 | 0.16 | Why? |
| Betacoronavirus | 10 | 2020 | 204454 | 0.16 | Why? |
| Forkhead Transcription Factors | 1 | 2017 | 231 | 0.16 | Why? |
| Osteopontin | 1 | 2017 | 96 | 0.15 | Why? |
| Universities | 3 | 2020 | 4374 | 0.15 | Why? |
| Male | 21 | 2021 | 367725 | 0.15 | Why? |
| Repressor Proteins | 1 | 2017 | 232 | 0.15 | Why? |
| Genetic Association Studies | 1 | 2019 | 559 | 0.15 | Why? |
| Female | 21 | 2021 | 380317 | 0.15 | Why? |
| Biphenyl Compounds | 1 | 2017 | 249 | 0.15 | Why? |
| Students, Health Occupations | 1 | 2018 | 224 | 0.15 | Why? |
| Truth Disclosure | 1 | 2018 | 196 | 0.15 | Why? |
| Platelet Activation | 1 | 2019 | 660 | 0.14 | Why? |
| Transients and Migrants | 2 | 2017 | 1468 | 0.14 | Why? |
| Animals | 7 | 2019 | 78931 | 0.14 | Why? |
| Myocytes, Cardiac | 1 | 2021 | 804 | 0.14 | Why? |
| Promoter Regions, Genetic | 1 | 2018 | 823 | 0.14 | Why? |
| Reoperation | 1 | 2017 | 544 | 0.14 | Why? |
| Choice Behavior | 1 | 2018 | 319 | 0.14 | Why? |
| Air Pollution, Indoor | 2 | 2020 | 816 | 0.14 | Why? |
| Gene Frequency | 1 | 2019 | 1210 | 0.14 | Why? |
| Insulin-Secreting Cells | 1 | 2017 | 273 | 0.14 | Why? |
| Tetrazoles | 1 | 2017 | 262 | 0.14 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 2 | 2017 | 5277 | 0.14 | Why? |
| Stem Cells | 2 | 2011 | 595 | 0.13 | Why? |
| Latent Tuberculosis | 1 | 2018 | 324 | 0.13 | Why? |
| Inflammation | 1 | 2017 | 13255 | 0.13 | Why? |
| Diabetic Foot | 1 | 2018 | 317 | 0.13 | Why? |
| Toll-Like Receptors | 1 | 2017 | 365 | 0.13 | Why? |
| Hypertension | 2 | 2017 | 8895 | 0.13 | Why? |
| Population Surveillance | 1 | 2010 | 4967 | 0.13 | Why? |
| Students, Dental | 1 | 2015 | 210 | 0.13 | Why? |
| Cells, Cultured | 2 | 2017 | 5835 | 0.13 | Why? |
| Prognosis | 4 | 2021 | 32490 | 0.13 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.12 | Why? |
| Residential Facilities | 1 | 2018 | 443 | 0.12 | Why? |
| Serologic Tests | 2 | 2017 | 4359 | 0.12 | Why? |
| Emigration and Immigration | 1 | 2018 | 501 | 0.12 | Why? |
| Communicable Diseases | 2 | 2018 | 2148 | 0.12 | Why? |
| Middle Aged | 15 | 2021 | 270681 | 0.12 | Why? |
| Health Personnel | 2 | 2020 | 29646 | 0.12 | Why? |
| Induced Pluripotent Stem Cells | 1 | 2017 | 584 | 0.12 | Why? |
| Food Hypersensitivity | 1 | 2018 | 397 | 0.12 | Why? |
| Dysbiosis | 1 | 2018 | 685 | 0.12 | Why? |
| Cardiovascular System | 1 | 2020 | 750 | 0.12 | Why? |
| Public Health | 1 | 2018 | 16359 | 0.12 | Why? |
| Cardiac Rehabilitation | 1 | 2018 | 525 | 0.12 | Why? |
| Inositol | 1 | 2011 | 28 | 0.12 | Why? |
| Catechols | 1 | 2011 | 43 | 0.12 | Why? |
| Isoprostanes | 1 | 2011 | 22 | 0.11 | Why? |
| Pandemics | 13 | 2020 | 389249 | 0.11 | Why? |
| Tunica Intima | 1 | 2011 | 27 | 0.11 | Why? |
| Gene Regulatory Networks | 1 | 2017 | 820 | 0.11 | Why? |
| Hygiene | 1 | 2018 | 987 | 0.11 | Why? |
| Young Adult | 8 | 2020 | 93724 | 0.11 | Why? |
| Interleukin-10 | 1 | 2018 | 1409 | 0.11 | Why? |
| Cell Differentiation | 1 | 2017 | 1338 | 0.11 | Why? |
| Nitrites | 1 | 2011 | 43 | 0.11 | Why? |
| Disease Notification | 1 | 2017 | 639 | 0.11 | Why? |
| Lung | 1 | 2020 | 31049 | 0.11 | Why? |
| Insulin Resistance | 1 | 2017 | 669 | 0.11 | Why? |
| Biomarkers | 4 | 2018 | 23361 | 0.11 | Why? |
| Genome-Wide Association Study | 1 | 2018 | 1648 | 0.11 | Why? |
| Nitrates | 1 | 2011 | 98 | 0.11 | Why? |
| Health Knowledge, Attitudes, Practice | 3 | 2020 | 8811 | 0.11 | Why? |
| Cell Count | 1 | 2011 | 228 | 0.11 | Why? |
| Adult | 12 | 2020 | 244371 | 0.11 | Why? |
| Patient Compliance | 1 | 2020 | 1468 | 0.10 | Why? |
| Probiotics | 1 | 2018 | 694 | 0.10 | Why? |
| RNA-Binding Proteins | 1 | 2017 | 1022 | 0.10 | Why? |
| Swine | 1 | 2019 | 3352 | 0.10 | Why? |
| Risk Factors | 7 | 2020 | 71621 | 0.10 | Why? |
| Adjuvants, Immunologic | 1 | 2019 | 1709 | 0.10 | Why? |
| Exercise Therapy | 1 | 2018 | 976 | 0.10 | Why? |
| NF-kappa B | 1 | 2017 | 1301 | 0.10 | Why? |
| Drug Therapy, Combination | 2 | 2021 | 7268 | 0.10 | Why? |
| Infectious Disease Transmission, Professional-to-Patient | 1 | 2017 | 1316 | 0.10 | Why? |
| Up-Regulation | 1 | 2017 | 2249 | 0.10 | Why? |
| Controlled Clinical Trials as Topic | 1 | 2009 | 53 | 0.10 | Why? |
| Exercise | 2 | 2020 | 6771 | 0.09 | Why? |
| Vitamin E | 1 | 2009 | 128 | 0.09 | Why? |
| Pilot Projects | 2 | 2020 | 5182 | 0.09 | Why? |
| Follow-Up Studies | 3 | 2020 | 17020 | 0.09 | Why? |
| Regional Blood Flow | 1 | 2009 | 172 | 0.09 | Why? |
| Clinical Protocols | 1 | 2020 | 2734 | 0.09 | Why? |
| Immunoglobulins, Intravenous | 1 | 2021 | 2705 | 0.09 | Why? |
| Apolipoproteins E | 1 | 2009 | 170 | 0.09 | Why? |
| Aged | 13 | 2021 | 215776 | 0.09 | Why? |
| Cross Infection | 4 | 2020 | 8675 | 0.09 | Why? |
| Precision Medicine | 1 | 2018 | 1477 | 0.09 | Why? |
| Ventricular Function, Left | 1 | 2017 | 1555 | 0.09 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2018 | 2483 | 0.09 | Why? |
| Tuberculosis, Pulmonary | 1 | 2018 | 1171 | 0.09 | Why? |
| Immunization | 1 | 2017 | 2019 | 0.09 | Why? |
| Phenotype | 1 | 2019 | 4037 | 0.09 | Why? |
| Hematologic Neoplasms | 1 | 2021 | 2105 | 0.09 | Why? |
| Epidemiological Monitoring | 1 | 2020 | 3493 | 0.08 | Why? |
| Europe | 3 | 2019 | 12702 | 0.08 | Why? |
| Chronic Disease | 2 | 2019 | 5139 | 0.08 | Why? |
| Age of Onset | 1 | 2009 | 557 | 0.08 | Why? |
| Treatment Outcome | 4 | 2021 | 51732 | 0.08 | Why? |
| Refugees | 1 | 2017 | 809 | 0.08 | Why? |
| Arginine | 1 | 2009 | 377 | 0.08 | Why? |
| Graft Rejection | 1 | 2017 | 1766 | 0.08 | Why? |
| Cross-Sectional Studies | 5 | 2020 | 53120 | 0.08 | Why? |
| Carotid Stenosis | 1 | 2009 | 207 | 0.08 | Why? |
| Metabolic Diseases | 1 | 2011 | 505 | 0.08 | Why? |
| Surveys and Questionnaires | 5 | 2020 | 43792 | 0.08 | Why? |
| Fetus | 1 | 2009 | 484 | 0.07 | Why? |
| Neovascularization, Pathologic | 1 | 2009 | 305 | 0.07 | Why? |
| Angioplasty, Balloon, Coronary | 1 | 2009 | 365 | 0.07 | Why? |
| Polymerase Chain Reaction | 1 | 2020 | 6740 | 0.07 | Why? |
| Glucocorticoids | 1 | 2021 | 4431 | 0.07 | Why? |
| Endothelium, Vascular | 2 | 2009 | 1751 | 0.07 | Why? |
| Antihypertensive Agents | 1 | 2017 | 1962 | 0.07 | Why? |
| Renin-Angiotensin System | 1 | 2020 | 3661 | 0.07 | Why? |
| Gene Expression Regulation | 1 | 2017 | 4020 | 0.07 | Why? |
| Immunization, Passive | 1 | 2021 | 10067 | 0.07 | Why? |
| Mice | 2 | 2017 | 21357 | 0.07 | Why? |
| Electrocardiography | 1 | 2018 | 3957 | 0.07 | Why? |
| Randomized Controlled Trials as Topic | 2 | 2021 | 10649 | 0.07 | Why? |
| Infection Control | 3 | 2018 | 23131 | 0.07 | Why? |
| Machine Learning | 1 | 2020 | 4395 | 0.07 | Why? |
| Retrospective Studies | 3 | 2020 | 105322 | 0.07 | Why? |
| Ultrasonography | 2 | 2011 | 4409 | 0.07 | Why? |
| Survival Analysis | 1 | 2017 | 7592 | 0.07 | Why? |
| Ascorbic Acid | 1 | 2009 | 676 | 0.06 | Why? |
| Regression Analysis | 1 | 2011 | 2484 | 0.06 | Why? |
| Angina, Unstable | 1 | 2003 | 110 | 0.06 | Why? |
| Seroepidemiologic Studies | 1 | 2019 | 10017 | 0.06 | Why? |
| Influenza Vaccines | 1 | 2019 | 2941 | 0.06 | Why? |
| Metabolomics | 1 | 2008 | 921 | 0.06 | Why? |
| Carbamazepine | 1 | 2021 | 34 | 0.06 | Why? |
| Muscle, Smooth, Vascular | 1 | 2002 | 86 | 0.06 | Why? |
| Primary Prevention | 1 | 2009 | 778 | 0.06 | Why? |
| Drug Repositioning | 1 | 2021 | 5683 | 0.06 | Why? |
| Risk Assessment | 4 | 2020 | 25439 | 0.06 | Why? |
| Health Behavior | 1 | 2020 | 4449 | 0.06 | Why? |
| Predictive Value of Tests | 1 | 2017 | 9537 | 0.06 | Why? |
| Case-Control Studies | 2 | 2019 | 17671 | 0.06 | Why? |
| Computational Biology | 1 | 2017 | 4514 | 0.06 | Why? |
| Ischemia | 1 | 2009 | 901 | 0.06 | Why? |
| Heart Diseases | 1 | 2018 | 3503 | 0.05 | Why? |
| Construction Materials | 1 | 2020 | 57 | 0.05 | Why? |
| Atherosclerosis | 1 | 2009 | 768 | 0.05 | Why? |
| Models, Statistical | 1 | 2018 | 5312 | 0.05 | Why? |
| Reproducibility of Results | 1 | 2017 | 11304 | 0.05 | Why? |
| Endothelial Cells | 1 | 2011 | 2048 | 0.05 | Why? |
| Heating | 1 | 2020 | 100 | 0.05 | Why? |
| Age Factors | 2 | 2018 | 21039 | 0.05 | Why? |
| Attitude of Health Personnel | 1 | 2018 | 4741 | 0.05 | Why? |
| Triiodothyronine | 1 | 2021 | 201 | 0.05 | Why? |
| Communicable Disease Control | 2 | 2020 | 29620 | 0.05 | Why? |
| Time Factors | 2 | 2020 | 31397 | 0.05 | Why? |
| Anticoagulants | 1 | 2021 | 9563 | 0.05 | Why? |
| Depression | 2 | 2020 | 14116 | 0.05 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 9335 | 0.05 | Why? |
| Homeostasis | 1 | 2002 | 582 | 0.04 | Why? |
| Air Conditioning | 1 | 2020 | 215 | 0.04 | Why? |
| Prevalence | 1 | 2020 | 25773 | 0.04 | Why? |
| Host-Pathogen Interactions | 1 | 2018 | 11041 | 0.04 | Why? |
| Hospital Design and Construction | 1 | 2020 | 287 | 0.04 | Why? |
| Europe, Eastern | 1 | 2017 | 88 | 0.04 | Why? |
| C-Reactive Protein | 2 | 2017 | 7972 | 0.04 | Why? |
| Hospital Mortality | 2 | 2021 | 22087 | 0.04 | Why? |
| Disease Progression | 2 | 2009 | 13580 | 0.04 | Why? |
| Protein Structure, Secondary | 1 | 2021 | 1077 | 0.04 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.04 | Why? |
| Toilet Facilities | 1 | 2017 | 88 | 0.04 | Why? |
| Mass Screening | 1 | 2017 | 8005 | 0.04 | Why? |
| Life Style | 1 | 2009 | 2708 | 0.04 | Why? |
| Adolescent | 4 | 2020 | 86841 | 0.04 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.04 | Why? |
| Pulse Wave Analysis | 1 | 2017 | 221 | 0.04 | Why? |
| Africa, Northern | 1 | 2017 | 539 | 0.04 | Why? |
| Aged, 80 and over | 5 | 2021 | 88759 | 0.04 | Why? |
| Statistics, Nonparametric | 1 | 2018 | 1008 | 0.04 | Why? |
| Filtration | 1 | 2020 | 820 | 0.03 | Why? |
| Pregnancy | 1 | 2017 | 23879 | 0.03 | Why? |
| Chromatography, High Pressure Liquid | 1 | 2018 | 669 | 0.03 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.03 | Why? |
| Geriatrics | 1 | 2003 | 947 | 0.03 | Why? |
| Vascular Stiffness | 1 | 2017 | 264 | 0.03 | Why? |
| Ventilation | 1 | 2020 | 1145 | 0.03 | Why? |
| Influenza B virus | 1 | 2019 | 815 | 0.03 | Why? |
| Nervous System Diseases | 1 | 2011 | 4092 | 0.03 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.03 | Why? |
| Research Design | 1 | 2009 | 5830 | 0.03 | Why? |
| Hospitalization | 2 | 2020 | 54280 | 0.03 | Why? |
| Magnetic Resonance Imaging | 1 | 2009 | 6551 | 0.03 | Why? |
| Middle East | 1 | 2017 | 1418 | 0.03 | Why? |
| Logistic Models | 2 | 2018 | 9089 | 0.03 | Why? |
| Equipment Contamination | 1 | 2020 | 1308 | 0.03 | Why? |
| Leukocytes, Mononuclear | 1 | 2021 | 2115 | 0.03 | Why? |
| RNA, Viral | 1 | 2019 | 32276 | 0.03 | Why? |
| Single-Cell Analysis | 1 | 2021 | 2450 | 0.03 | Why? |
| Workflow | 1 | 2020 | 2373 | 0.03 | Why? |
| Body Mass Index | 1 | 2003 | 4306 | 0.03 | Why? |
| Lipids | 1 | 2017 | 1079 | 0.03 | Why? |
| Disease Outbreaks | 1 | 2018 | 27595 | 0.02 | Why? |
| Equipment Design | 1 | 2020 | 3095 | 0.02 | Why? |
| Autopsy | 1 | 2021 | 3495 | 0.02 | Why? |
| Geriatric Assessment | 1 | 2018 | 1372 | 0.02 | Why? |
| Amino Acid Sequence | 1 | 2021 | 6049 | 0.02 | Why? |
| Commerce | 1 | 2018 | 1109 | 0.02 | Why? |
| Health Surveys | 1 | 2020 | 2841 | 0.02 | Why? |
| Quality of Health Care | 1 | 2020 | 1948 | 0.02 | Why? |
| Particulate Matter | 1 | 2020 | 3249 | 0.02 | Why? |
| Hospitals | 2 | 2018 | 11793 | 0.02 | Why? |
| Myocardial Infarction | 1 | 2003 | 3361 | 0.02 | Why? |
| Seasons | 1 | 2019 | 4071 | 0.02 | Why? |
| Patient Care Team | 1 | 2020 | 3556 | 0.02 | Why? |
| Stroke | 1 | 2009 | 8839 | 0.02 | Why? |
| Double-Blind Method | 1 | 2017 | 5988 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2018 | 51949 | 0.02 | Why? |
| Blood Pressure | 1 | 2017 | 2198 | 0.02 | Why? |
| Inflammation Mediators | 1 | 2017 | 2654 | 0.02 | Why? |
| Environmental Monitoring | 1 | 2017 | 3143 | 0.02 | Why? |
| Disinfection | 1 | 2018 | 2912 | 0.02 | Why? |
| Influenza A Virus, H1N1 Subtype | 1 | 2019 | 2984 | 0.02 | Why? |
| Anxiety | 2 | 2020 | 17311 | 0.02 | Why? |
| Protein Binding | 1 | 2021 | 11430 | 0.02 | Why? |
| Algorithms | 1 | 2020 | 7346 | 0.02 | Why? |
| Blood Glucose | 1 | 2017 | 3642 | 0.02 | Why? |
| Vaccination | 2 | 2019 | 19050 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2009 | 25144 | 0.01 | Why? |
| Societies, Medical | 1 | 2018 | 6907 | 0.01 | Why? |
| Coronary Care Units | 1 | 2003 | 224 | 0.01 | Why? |
| Aerosols | 1 | 2017 | 5393 | 0.01 | Why? |
| Social Isolation | 1 | 2020 | 5932 | 0.01 | Why? |
| Angiotensin Receptor Antagonists | 1 | 2017 | 3892 | 0.01 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2017 | 11367 | 0.01 | Why? |
| Cohort Studies | 1 | 2021 | 36005 | 0.01 | Why? |
| Infant, Newborn | 1 | 2017 | 23105 | 0.01 | Why? |
| Infant | 1 | 2017 | 30274 | 0.01 | Why? |
| Health Services Accessibility | 1 | 2017 | 10697 | 0.01 | Why? |
| Prospective Studies | 1 | 2018 | 43301 | 0.01 | Why? |
| Child, Preschool | 1 | 2017 | 36283 | 0.01 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.01 | Why? |
| Child | 1 | 2017 | 70012 | 0.01 | Why? |